@article{206f972ca35f40b090eabac1dffda031,
title = "Letter by Asinger et al Regarding Articles, {"}should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke{"} and {"}should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower end of the Risk Spectrum{"}",
author = "Asinger, {Richard W.} and Shroff, {Gautam R.} and Herzog, {Charles A.}",
note = "Funding Information: Dr Herzog has equity interest (stock ownership) in Johnson and Johnson and research support from Johnson and Johnson. He also was a consultant for Bristol Myers Squibb, 2015",
year = "2016",
month = nov,
day = "1",
doi = "10.1161/CIRCULATIONAHA.116.023650",
language = "English (US)",
volume = "134",
pages = "e387--e388",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "18",
}